Decision Aid Summary

Title Juvenile Idiopathic Arthritis Treatment: Arthritis Medication Choice Cards.
Audience Parents of, and children with, juvenile idiopathic arthritis considering medications.
Options included Leflunomide, Sulfasalazine
Methotrexate
Etanercept, Adalimumab, Anakinra, Canakinumab
Abatacept, Infliximab, Rituximab, Tocilizuma
Year of last update or review 2013
Format Web, paper, PDF
How to obtain Click here to view the decision aid on the developer website
Developer James M. Anderson Center for Health Systems Excellence
Where was it developed? http://www.cincinnatichildrens.org/service/j/anderson-center/evidence-based-care
Cincinnati Children's Hospital Medical Center
US
Health condition Juvenile Rheumatoid Arthritis
Type of decision aid Treatment
Language English
Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:
7 out of 7 criteria to be defined as a patient decision aid
6 out of 8 criteria to lower the risk of making a biased decision
Not applicable: other criteria for decision aids about screening or testing

Last modified: 2017-04-06.